4//SEC Filing
Daniel William F 4
Accession 0001209191-22-026464
CIK 0001492426other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 6:04 PM ET
Size
11.0 KB
Accession
0001209191-22-026464
Insider Transaction Report
Form 4
Daniel William F
Director
Transactions
- Tax Payment
Ordinary Shares
2022-04-29$98.56/sh−1,139$112,260→ 77,551 total(indirect: By Trust) - Exercise/Conversion
Restricted Stock Units
2022-04-29−4,223→ 0 totalFrom: 2022-04-29Exp: 2022-04-29→ Ordinary shares (4,223 underlying) - Exercise/Conversion
Ordinary Shares
2022-04-29+4,223→ 78,690 total(indirect: By Trust) - Award
Restricted Stock Units
2022-04-28+3,913→ 3,913 totalFrom: 2023-04-28Exp: 2023-04-28→ Ordinary shares (3,913 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001529409
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 6:04 PM ET
- Size
- 11.0 KB